|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| High Throughput Smart Screening | ||||||||||||||||
| August 28, 2002 | ||||||||||||||||
|
IBC Life Sciences, Thistle Marble Arch Hotel, London 26 - 27 November 2002 In addition to covering updates in the established areas of HTS, the conference will be a look at the business implications and the maximisation of HTS screening. New topics that will be covered are: - HCS (High Content Screening) - Dealing with bottlenecks that arise from HTS - Improving the quality of hits - In silico/Virtual screening - Maximising the extraction of knowledge out of profiling data - Data capture - Informatics and Knowledge Management - Visual data mining - Data management - IT Solutions What Can You Do To Speed Up Drug Discovery? • Learn what is new and innovative in chemical screening • Hear about new developing assay techniques • Optimise at early stage discovery • Discover how to screen with multiple parameters • Look beyond automated processes • Review the latest uHTS advances |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Invited Speakers: | Hear HTS Case Studies & Reviews from Leading Companies, Including: Aventis Pharma Merck Sharp & Dohme Boehringer Ingelheim Schering AstraZenenca Bristol Myers Squibb 3 Dimensional Pharmaceuticals University of Cambridge |
|||||||||||||||
| Deadline for Abstracts: | 11-10-2002 | |||||||||||||||
| Registration: | ||||||||||||||||
| E-mail: | Cust.serv@informa.com | |||||||||||||||
| Posted by: | Chris Marshall | |||||||||||||||
| Host: | dc-01.informa.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||